What is a stock summary page? Click here for an overview.
Business Description
Raia Drogasil SA
ISIN : BRRADLACNOR0
Share Class Description:
BSP:RADL3: Ordinary SharesCompare
Compare
Traded in other countries / regions
RADL3.BrazilRADLY.USA Index Membership
iShares MSCI ACWI Ex US Index Fund IPO Date
1995-05-02Description
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 1.2 | |||||
| Debt-to-EBITDA | 2.14 | |||||
| Interest Coverage | 3 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.63 | |||||
| Beneish M-Score | -2.72 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.7 | |||||
| 3-Year EBITDA Growth Rate | 7.5 | |||||
| 3-Year EPS without NRI Growth Rate | 18.3 | |||||
| 3-Year FCF Growth Rate | -2.3 | |||||
| 3-Year Book Growth Rate | 11.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 18.77 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.05 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.21 | |||||
| 9-Day RSI | 46.07 | |||||
| 14-Day RSI | 49.62 | |||||
| 3-1 Month Momentum % | -5.31 | |||||
| 6-1 Month Momentum % | -21.62 | |||||
| 12-1 Month Momentum % | -22.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.38 | |||||
| Quick Ratio | 0.47 | |||||
| Cash Ratio | 0.06 | |||||
| Days Inventory | 104.52 | |||||
| Days Sales Outstanding | 28.15 | |||||
| Days Payable | 72.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.52 | |||||
| Dividend Payout Ratio | 0.45 | |||||
| 3-Year Dividend Growth Rate | 10.5 | |||||
| Forward Dividend Yield % | 1.52 | |||||
| 5-Year Yield-on-Cost % | 4.19 | |||||
| Shareholder Yield % | -0.66 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.72 | |||||
| Operating Margin % | 6.09 | |||||
| Net Margin % | 3.08 | |||||
| FCF Margin % | 1.62 | |||||
| ROE % | 19.36 | |||||
| ROA % | 5.67 | |||||
| ROIC % | 13.8 | |||||
| 3-Year ROIIC % | 20.87 | |||||
| ROC (Joel Greenblatt) % | 20.41 | |||||
| ROCE % | 17.59 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.49 | |||||
| Forward PE Ratio | 28.11 | |||||
| PE Ratio without NRI | 31.49 | |||||
| Shiller PE Ratio | 36.74 | |||||
| Price-to-Owner-Earnings | 29.02 | |||||
| PEG Ratio | 3.35 | |||||
| PS Ratio | 0.87 | |||||
| PB Ratio | 5.37 | |||||
| Price-to-Tangible-Book | 7.84 | |||||
| Price-to-Free-Cash-Flow | 53.31 | |||||
| Price-to-Operating-Cash-Flow | 17.58 | |||||
| EV-to-EBIT | 18.91 | |||||
| EV-to-Forward-EBIT | 18.5 | |||||
| EV-to-EBITDA | 11.6 | |||||
| EV-to-Forward-EBITDA | 12.96 | |||||
| EV-to-Revenue | 1.08 | |||||
| EV-to-Forward-Revenue | 0.97 | |||||
| EV-to-FCF | 67.75 | |||||
| Price-to-GF-Value | 0.6 | |||||
| Price-to-Projected-FCF | 3.35 | |||||
| Price-to-DCF (Earnings Based) | 1.35 | |||||
| Price-to-DCF (FCF Based) | 4.62 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.34 | |||||
| Price-to-Graham-Number | 3.31 | |||||
| Earnings Yield (Greenblatt) % | 5.28 | |||||
| FCF Yield % | 1.82 | |||||
| Forward Rate of Return (Yacktman) % | 14.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Raia Drogasil SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 38,864.455 | ||
| EPS (TTM) (R$) | 0.64 | ||
| Beta | 1.04 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 25.26 | ||
| 14-Day RSI | 49.62 | ||
| 14-Day ATR (R$) | 0.782966 | ||
| 20-Day SMA (R$) | 20.2215 | ||
| 12-1 Month Momentum % | -22.44 | ||
| 52-Week Range (R$) | 17.15 - 30.4 | ||
| Shares Outstanding (Mil) | 1,713 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Raia Drogasil SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Raia Drogasil SA Stock Events
| Event | Date | Price (R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Raia Drogasil SA Frequently Asked Questions
What is Raia Drogasil SA(BSP:RADL3)'s stock price today?
The current price of BSP:RADL3 is R$20.15. The 52 week high of BSP:RADL3 is R$30.40 and 52 week low is R$17.15.
When is next earnings date of Raia Drogasil SA(BSP:RADL3)?
The next earnings date of Raia Drogasil SA(BSP:RADL3) is .
Does Raia Drogasil SA(BSP:RADL3) pay dividends? If so, how much?
The Dividend Yield %  of Raia Drogasil SA(BSP:RADL3) is 1.52% (As of Today), Highest Dividend Payout Ratio of Raia Drogasil SA(BSP:RADL3) was 0.56. The lowest was 0.34. And the median was 0.42. The  Forward Dividend Yield % of Raia Drogasil SA(BSP:RADL3) is 1.52%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers